MDNA Life Sciences Inc. (MDLS)

MDNA Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year	2021	2020
Cash & Equivalents	0.96	0.05
Cash & Cash Equivalents	0.96	0.05
Cash Growth	1801.44%	-
Receivables	0.18	0.06
Inventory	-	0.01
Other Current Assets	0.08	0.23
Total Current Assets	1.22	0.35
Property, Plant & Equipment	0.35	0.36
Goodwill and Intangibles	1.56	1.74
Other Long-Term Assets	0.06	0
Total Long-Term Assets	1.97	2.1
Total Assets	3.19	2.45
Accounts Payable	2.06	2.03
Deferred Revenue	0.71	0.47
Current Debt	15.46	0.71
Other Current Liabilities	1.36	0.78
Total Current Liabilities	19.59	4
Long-Term Debt	1.23	13.48
Total Long-Term Liabilities	1.23	13.48
Total Liabilities	20.82	17.48
Total Debt	16.69	14.19
Debt Growth	17.60%	-
Retained Earnings	-45.35	-41.56
Comprehensive Income	0.01	-0.01
Shareholders' Equity	-17.62	-15.03
Net Cash / Debt	-15.73	-14.14
Working Capital	-18.37	-3.65

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).